SEC Form 4 · accession 0001144204-16-089611
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Feb 12, 2016
Accepted (ET)
Mar 22, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF4,F2 | — | Feb 12, 2016 | A | 3,831 | A | — | — | Common Stock | 3,831 | 3,831 | D |
| Stock Option (Right to buy Common Stock)F1 | $3.03 | holding | — | — | — | — | Aug 11, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF2 | — | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to buy Common Stock)F3 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
Explanation of responses
- F1The options shall vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F2Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F3The options vest in full on the first anniversary of the date of grant.
- F4These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors fees.